- Home
- GPCR vs VRNT Comparison
GPCR vs VRNT Comparison
Compare GPCR & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- VRNT
- Stock Information
- Founded
- GPCR 2016
- VRNT 1994
- Country
- GPCR United States
- VRNT United States
- Employees
- GPCR N/A
- VRNT N/A
- Industry
- GPCR
- VRNT EDP Services
- Sector
- GPCR
- VRNT Technology
- Exchange
- GPCR Nasdaq
- VRNT Nasdaq
- Market Cap
- GPCR 1.6B
- VRNT 1.5B
- IPO Year
- GPCR 2023
- VRNT N/A
- Fundamental
- Price
- GPCR $23.77
- VRNT $24.29
- Analyst Decision
- GPCR Strong Buy
- VRNT Buy
- Analyst Count
- GPCR 7
- VRNT 7
- Target Price
- GPCR $81.29
- VRNT $35.67
- AVG Volume (30 Days)
- GPCR 752.3K
- VRNT 456.2K
- Earning Date
- GPCR 03-07-2025
- VRNT 03-26-2025
- Dividend Yield
- GPCR N/A
- VRNT N/A
- EPS Growth
- GPCR N/A
- VRNT 2980.37
- EPS
- GPCR N/A
- VRNT 0.95
- Revenue
- GPCR N/A
- VRNT $920,749,000.00
- Revenue This Year
- GPCR N/A
- VRNT $4.50
- Revenue Next Year
- GPCR N/A
- VRNT $4.50
- P/E Ratio
- GPCR N/A
- VRNT $25.45
- Revenue Growth
- GPCR N/A
- VRNT 4.45
- 52 Week Low
- GPCR $22.33
- VRNT $21.28
- 52 Week High
- GPCR $62.74
- VRNT $38.17
- Technical
- Relative Strength Index (RSI)
- GPCR 37.89
- VRNT 37.65
- Support Level
- GPCR $22.33
- VRNT $25.48
- Resistance Level
- GPCR $25.17
- VRNT $26.62
- Average True Range (ATR)
- GPCR 1.73
- VRNT 0.87
- MACD
- GPCR -0.37
- VRNT -0.08
- Stochastic Oscillator
- GPCR 15.94
- VRNT 12.46
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries helps brands provide Boundless Customer Engagement. The company's solutions help iconic brands close the gap created when it lacks the resources required to deliver experiences that fulfill customer expectations. Geographically, it derives a majority of its revenue from the United States.